Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects

Clinical trial NCT00840086 · COMPLETED

Trial details

NCT number: NCT00840086
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A

Start date: 2009-04-01
Primary completion: 2011-09-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.